Fig. 1From: Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II studyPatient #3 with a cervico-facial microcystic LM before initiation of sirolimus (a) and after 12 months of treatment (b)Back to article page